ALK and lung cancer: We examined ciliation in the EML4-ALK-fusion-positive lung cancer cell line NCI-H2228 (which is highly sensitive to the ALK inhibitor NVP-TAE684) and a drug-resistant derivative generated through chronic NVP-TAE684 exposure.